OncoCyte Corporation (NASDAQ:OCX) Q1 2021 Results Conference Call May 17, 2021 4:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors, LLC Ronnie Andrews - President and CEO Mitch Levine - CFO Dr. Doug Ross - Chief Science Officer Padma Sundar - Chief Commercial Officer Conference Call Participants Mike Matson - Needham & Company Mark Massaro - BTIG Thomas Flaten - Lake Street Steven Mah - Piper Sandler Paul Knight - KeyBanc Bruce Jackson - Benchmark Operator Good afternoon, ladies and gentlemen, ...

Investor Presentation Q1 2021 HONCOCYTE® Where Tomorrow LIVES Forward Looking Statement Oncocyte Forward Looking Statements. Oncocyte cautions you that this press release contains forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates," "may," and similar expressions) are forward-looking statements. These statements include those pertaining to the acquisitio ...

Oncocyte Corporation (NASDAQ:OCX) Q4 2020 Results Conference Call March 16, 2021 4:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors, LLC Ronnie Andrews - President and CEO Mitch Levine - CFO Dr. Doug Ross - Chief Science Officer Padma Sundar - Chief Commercial Officer Conference Call Participants Mike Matson - Needham & Company Mark Massaro - BTIG Steven Mah - Piper Sandler Thomas Flaten - Lake Street Capital Markets Bruce Jackson - Benchmark Company Paul Knight - KeyBanc Operator Greetings, a ...

Investor Presentation Q4 2020 HONCOCYTE® Where Tomorrow LIVES 1 | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

OncoCyte Corporation (NASDAQ:OCX) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Bob Yedid - Managing Director-LifeSci Advisors Ronnie Andrews - President and Chief Executive Officer Mitch Levine - Chief Financial Officer Dr. Doug Ross - Chief Medical Officer Padma Sundar - Senior Vice President of Commercial Conference Call Participants Mark Massaro - BTIG Paul Knight - KeyBanc Capital Markets Stephen Unger - Needham & Company Steven Mah - Piper Sandler & Co. Bruce Jacks ...

Oncocyte Corporation (NASDAQ:OCX) Q2 2020 Earnings Conference Call July 29, 2020 4:30 PM ET Company Participants Bob Yedid – Managing Director-LifeSci Advisors Ronnie Andrews – President and Chief Executive Officer Mitch Levine – Chief Financial Officer Al Parker – Chief Operating Officer Dr. Doug Ross – Chief Medical Officer Padma Sundar – Senior Vice President of Commercial Conference Call Participants Thomas Flaten – Lake Street Capital Markets Steve Unger – Needham Steven Mah – Piper Sandler Bruce Jacks ...

Start Time: 16:30 January 1, 0000 5:29 PM ET Oncocyte Corporation (NASDAQ:OCX) Q1 2020 Earnings Conference Call May 12, 2020, 16:30 PM ET Company Participants Ronald Andrews - President and CEO Mitch Levine - CFO Padma Sundar - SVP, Commercial Doug Ross - Chief Medical Officer Lyndal Hesterberg - Chief Scientific Officer Bob Yedid - Investor Relations, LifeSci Advisors Conference Call Participants Thomas Flaten - Lake Street Capital Markets Steven Mah - Piper Sandler Paul Knight - Janney Montgomery Scott Ke ...

OncoCyte Corporation (NASDAQ:OCX) Q4 2019 Results Earnings Conference Call March 25, 2020 4:30 PM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Ronald Andrews - President and Chief Executive Officer Mitch Levine - Chief Financial Officer Padma Sundar - Senior Vice President of Marketing & Market Access Doug Ross - Chief Medical Officer Lyndal Hesterberg - Chief Scientific Officer Conference Call Participants Paul Knight - Janney Capital Markets Bruce Jackson - The Benchmark Compan ...

| --- | --- | --- | --- | |-------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | WHERE TOMORROW LIVES. | | | | | | | | | | Investor Presentation January 2020 | | | | Forward looking statements Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates" and similar expressions) are forward-looking statements. These statements include those ...

OncoCyte Corporation. (NASDAQ:OCX) Q3 2019 Results Earnings Conference Call November 14, 2019 4:30 PM ET Company Participants Bob Yedid - LifeSci Advisors Ronald Andrews - CEO, President Al Parker - Chief Operating Officer Mitchell Levine - CFO Padma Sundar - Senior Vice President of Marketing and Market Access Tony Kalajian - Chief Accounting Officer Conference Call Participants Paul Knight - Janney Montgomery Scott Bill Quirk - Piper Jaffray Thomas Flaten - Lake Street Capital Markets Bruce Jackson - The ...